SCHEMBL6472114

SCHEMBL6472114

CCN(C(=O)C1(C(F)(F)F)CCCCC1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
GLA P06280 1/20 0.49
TSHR P16473 1/20 0.49
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
SIGMAR1 Q99720 3/20 0.42
POLB P06746 1/20 0.41
RIPK1 Q13546 2/20 0.41
TP53 P04637 2/20 0.40
OPRM1 P35372 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MLYCD O95822 1/20 0.38
HTT P42858 1/20 0.38
PRCP P42785 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913174 0.82 RIPK1 (0.44) ALDH1A1MEN1KMT2APOLBRIPK1
SCHEMBL518233 0.81 ALDH1A1 (0.53) ALDH1A1GLATSHRSLC6A2SLC6A4
SCHEMBL6470512 0.80 ALDH1A1 (0.45) ALDH1A1GLATSHRSLC6A2SLC6A4
SCHEMBL4862025 0.78 ALDH1A1 (0.53) ALDH1A1GLATSHRSLC6A2SLC6A4
SCHEMBL4558508 0.77 SLC6A2 (0.53) ALDH1A1GLATSHRSLC6A2SLC6A4
SCHEMBL5538599 0.76 ALDH1A1 (0.50) ALDH1A1GLATSHRSLC6A2SLC6A4
Hydrochloric Acid SCHEMBL6926710 0.75 ALDH1A1 (0.49) ALDH1A1GLATSHRSLC6A2SLC6A4
SCHEMBL2432523 0.74 ALDH1A1 (0.51) ALDH1A1GLATSHRSLC6A2SLC6A4
SCHEMBL2432094 0.74 ALDH1A1 (0.51) ALDH1A1GLATSHRSLC6A2SLC6A4
SCHEMBL2595399 0.73 TSHR (0.62) ALDH1A1GLATSHRSLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197350-A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof TAISHO PHARMACEUTICAL CO., LTD. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197350-A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof HCRTR2, MCHR1, MCHR2 ALDH1A1 2036/4885GLA 4584/4885TSHR 156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.